Glioblastoma multiforme (GBM) is characterized by poor prognosis despite an aggressive therapeutic strategy. In recent years, many advances have been achieved in the field of glioblastoma biology. Here we try to summarize the main clinical and biological factors impacting clinical prog-nostication and therapy of GBM patients. From that standpoint, hopefully, in the near future, personalized therapies will be available.
Glioblastoma: Prognostic factors and predictive response to radio-and chemotherapy
Fiorica, F.
Primo
;Giuliani ,J.;Perrone, Maria Sole;Missiroli, SoniaPenultimo
;Giorgi, CarlottaUltimo
2020
Abstract
Glioblastoma multiforme (GBM) is characterized by poor prognosis despite an aggressive therapeutic strategy. In recent years, many advances have been achieved in the field of glioblastoma biology. Here we try to summarize the main clinical and biological factors impacting clinical prog-nostication and therapy of GBM patients. From that standpoint, hopefully, in the near future, personalized therapies will be available.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Glioblastoma- Prognostic Factors and Predictive Response to Radioand Chemotherapy.pdf
solo gestori archivio
Descrizione: versione editoriale
Tipologia:
Full text (versione editoriale)
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
575.32 kB
Formato
Adobe PDF
|
575.32 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
